Cargando…
Clinical Predictors of Lung-Function Decline in Systemic-Sclerosis-Associated Interstitial Lung Disease Patients with Normal Spirometry
Interstitial lung disease (ILD) is the leading cause of mortality in systemic sclerosis (SSc). Progressive pulmonary fibrosis (PPF) is defined as progression in 2 domains including clinical, radiological or lung-function parameters. Our aim was to assess predictors of functional decline in SSc-ILD p...
Autores principales: | Nagy, Tamas, Toth, Nora Melinda, Palmer, Erik, Polivka, Lorinc, Csoma, Balazs, Nagy, Alexandra, Eszes, Noémi, Vincze, Krisztina, Bárczi, Enikő, Bohács, Anikó, Tárnoki, Ádám Domonkos, Tárnoki, Dávid László, Nagy, György, Kiss, Emese, Maurovich-Horvát, Pál, Müller, Veronika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495755/ https://www.ncbi.nlm.nih.gov/pubmed/36140231 http://dx.doi.org/10.3390/biomedicines10092129 |
Ejemplares similares
-
Treatment and Systemic Sclerosis Interstitial Lung Disease Outcome: The Overweight Paradox
por: Nagy, Alexandra, et al.
Publicado: (2022) -
Autoimmune Progressive Fibrosing Interstitial Lung Disease: Predictors of Fast Decline
por: Nagy, Alexandra, et al.
Publicado: (2021) -
Impact of interstitial lung disease and simultaneous lung cancer on therapeutic possibilities and survival
por: Barczi, Eniko, et al.
Publicado: (2020) -
Serum Progranulin Level Might Differentiate Non-IPF ILD from IPF
por: Tóth, Nóra Melinda, et al.
Publicado: (2023) -
Serological findings following the second and third SARS‐CoV‐2 vaccines in lung transplant recipients
por: Bárczi, Enikő, et al.
Publicado: (2022)